Standout Papers

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/indepe... 2014 2026 2018 2022 439
  1. Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine (2014)
    Lawrence M. Gelbert, Shufen Cai et al. Investigational New Drugs

Immediate Impact

4 from Science/Nature 81 standout
Sub-graph 1 of 20

Citing Papers

Unlocking Chiral Sulfinimidoyl Electrophiles: Asymmetric Synthesis of Sulfinamides Catalyzed by Anionic Stereogenic-at-Cobalt(III) Complexes
2025 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
6 intermediate papers

Works of Concepción Sánchez‐Martínez being referenced

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
2015
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
2014 Standout

Author Peers

Author Last Decade Papers Cites
Concepción Sánchez‐Martínez 710 331 43 740 21 1.1k
Swaminathan Murugappan 197 334 20 374 27 1.3k
Karoline Kollmann 226 606 8 405 31 1.2k
Alison Bigley 283 759 22 553 21 1.4k
Helen E. McGrath 188 522 78 290 33 1.2k
Christine Stephan 238 880 11 390 19 1.3k
R. Christopher Harmon 147 431 14 355 13 1.1k
Marianna Gallo 315 574 3 676 37 1.3k
Stéphanie Pesant 162 499 18 234 15 1.2k
Tim P. Green 155 696 8 502 14 1.2k
Teeru Bihani 341 519 3 381 27 1.1k

All Works

Loading papers...

Rankless by CCL
2026